Mimedx Group Inc (NASDAQ: MDXG) on Tuesday, plunged -3.24% from the previous trading day, before settling in for the closing price of $7.09. Within the past 52 weeks, MDXG’s price has moved between $5.47 and $10.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 3.85%. The company achieved an average annual earnings per share of -2.86%. With a float of $115.90 million, this company’s outstanding shares have now reached $146.93 million.
The extent of productivity of a business whose workforce counts for 837 workers is very important to gauge. In terms of profitability, gross margin is 82.67%, operating margin of 16.89%, and the pretax margin is 16.42%.
Mimedx Group Inc (MDXG) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Mimedx Group Inc is 21.36%, while institutional ownership is 49.79%. The most recent insider transaction that took place on Mar 17 ’25, was worth 14,142. In this transaction Chief Commercial Officer of this company sold 1,759 shares at a rate of $8.04, taking the stock ownership to the 309,077 shares. Before that another transaction happened on Mar 13 ’25, when Company’s General Counsel and CAO sold 54,596 for $7.89, making the entire transaction worth $430,762. This insider now owns 440,178 shares in total.
Mimedx Group Inc (MDXG) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -2.86% per share during the next fiscal year.
Mimedx Group Inc (NASDAQ: MDXG) Trading Performance Indicators
Mimedx Group Inc (MDXG) is currently performing well based on its current performance indicators. A quick ratio of 3.69 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.90. Likewise, its price to free cash flow for the trailing twelve months is 15.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.28, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.36 in one year’s time.
Technical Analysis of Mimedx Group Inc (MDXG)
The latest stats from [Mimedx Group Inc, MDXG] show that its last 5-days average volume of 0.58 million was inferior to 0.58 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 19.31%. Additionally, its Average True Range was 0.33.
During the past 100 days, Mimedx Group Inc’s (MDXG) raw stochastic average was set at 4.37%, which indicates a significant decrease from 10.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.81% in the past 14 days, which was lower than the 45.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.05, while its 200-day Moving Average is $7.54. Now, the first resistance to watch is $7.17. This is followed by the second major resistance level at $7.48. The third major resistance level sits at $7.67. If the price goes on to break the first support level at $6.66, it is likely to go to the next support level at $6.47. Assuming the price breaks the second support level, the third support level stands at $6.16.
Mimedx Group Inc (NASDAQ: MDXG) Key Stats
Market capitalization of the company is 1.01 billion based on 147,366K outstanding shares. Right now, sales total 348,880 K and income totals 42,420 K. The company made 92,910 K in profit during its latest quarter, and 7,440 K in sales during its previous quarter.
